We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+20.36%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$88.3B
AUM Growth
+$11B
Cap. Flow
-$1.46B
Cap. Flow %
-1.65%
Top 10 Hldgs %
29.94%
Holding
1,471
New
79
Increased
623
Reduced
633
Closed
76

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$185M
2
CLX icon
Clorox
CLX
+$182M
3
HSY icon
Hershey
HSY
+$170M
4
PEP icon
PepsiCo
PEP
+$169M
5
LRCX icon
Lam Research
LRCX
+$161M

Top Sells

Rank Stock Value
1
CTVA icon
Corteva
CTVA
+$252M
2
VEEV icon
Veeva Systems
VEEV
+$238M
3
GILD icon
Gilead Sciences
GILD
+$227M
4
MO icon
Altria Group
MO
+$209M
5
EFX icon
Equifax
EFX
+$198M

Sector Composition

Rank Sector Weight
1 Technology 43.08%
2 Materials 23.94%
3 Industrials 7.62%
4 Healthcare 6.11%
5 Financials 4.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FHI icon
1326
Federated Hermes
FHI
$4.74B
$51K ﹤0.01%
1,162
-39
-3% -$1.6K
ARWR icon
1327
Arrowhead Research
ARWR
$12.1B
$49K ﹤0.01%
3,114
-68
-2% -$976
BYND icon
1328
Beyond Meat
BYND
$210M
$49K ﹤0.01%
13,910
+700
+5% +$2.03K
PDCO
1329
DELISTED
Patterson Companies, Inc.
PDCO
$48K ﹤0.01%
1,527
-121,777
-99% -$3.79M
QQQ icon
1330
Invesco QQQ Trust
QQQ
$487B
$43K ﹤0.01%
78
PINC
1331
DELISTED
Premier
PINC
$42K ﹤0.01%
1,913
-128
-6% -$2.76K
ANGL icon
1332
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.12B
$38K ﹤0.01%
1,312
-106
-7% -$3.02K
BZ icon
1333
Kanzhun
BZ
$6.89B
$38K ﹤0.01%
2,111
SHY icon
1334
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$37K ﹤0.01%
446
+50
+13% +$4.13K
TLT icon
1335
iShares 20+ Year Treasury Bond ETF
TLT
$40.8B
$35K ﹤0.01%
394
LMNR icon
1336
Limoneira
LMNR
$250M
$32K ﹤0.01%
2,015
-738
-27% -$11.7K
PHR icon
1337
Phreesia
PHR
$780M
$32K ﹤0.01%
1,133
+69
+6% +$1.75K
LKFT
1338
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$31K ﹤0.01%
1,111
OMCL icon
1339
Omnicell
OMCL
$1.72B
$31K ﹤0.01%
1,056
TDOC icon
1340
Teladoc Health
TDOC
$1.26B
$31K ﹤0.01%
3,584
-220
-6% -$1.59K
NLOP
1341
Net Lease Office Properties
NLOP
$173M
$30K ﹤0.01%
907
+3
+0.3% +$92
TWST icon
1342
Twist Bioscience
TWST
$7.86B
$30K ﹤0.01%
826
+58
+8% +$2K
RSP icon
1343
Invesco S&P 500 Equal Weight ETF
RSP
$100B
$28K ﹤0.01%
152
EVH icon
1344
Evolent Health
EVH
$527M
$27K ﹤0.01%
2,415
+249
+11% +$2.29K
IWD icon
1345
iShares Russell 1000 Value ETF
IWD
$84.3B
$26K ﹤0.01%
132
RAAX icon
1346
VanEck Inflation Allocation ETF
RAAX
$1.2B
$26K ﹤0.01%
849
BEAM icon
1347
Beam Therapeutics
BEAM
$2.74B
$25K ﹤0.01%
1,451
+147
+11% +$2.56K
CNS icon
1348
Cohen & Steers
CNS
$4.4B
$25K ﹤0.01%
338
-11
-3% -$845
CLOI icon
1349
VanEck CLO ETF
CLOI
$1.53B
$24K ﹤0.01%
452
FLTR icon
1350
VanEck IG Floating Rate ETF
FLTR
$3.04B
$24K ﹤0.01%
922

Similar funds

VanEck Associates's Q2 2025 Portfolio in Review

As of Q2 2025, VanEck Associates held 1,471 positions worth $88.3B, up 14% from $77.4B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

VanEck Associates's Q2 2025 filing shows 79 new, 623 increased, 633 reduced and 76 closed positions. Its largest new stake was Nordson: 762,014 shares worth $163M. The largest sale was Corteva, an estimated $252M.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 37% a quarter earlier, followed by Materials and Industrials.

  • VanEck Associates's largest Q2 2025 buy was Nordson: 762,014 shares worth $163M.
  • VanEck Associates added most to Applied Materials in Q2 2025, an estimated $185M increase.
  • VanEck Associates's biggest Q2 2025 reduction was Corteva, cutting an estimated $252M.
  • VanEck Associates fully exited US Steel in Q2 2025, selling an estimated $26.8M.
  • VanEck Associates's ten largest holdings make up 30% of its $88.3B portfolio in Q2 2025.
  • VanEck Associates opened 79 new positions and closed 76 in Q2 2025.
  • VanEck Associates's portfolio value rose 14% quarter-over-quarter to $88.3B.

Based on VanEck Associates's 13F filing for Q2 2025, filed 14 Aug 2025.